Preusser, MatthiasWinkler, FrankValiente, ManuelManegold, ChristianMoyal, ElizabethWidhalm, GeorgTonn, Jörg-ChristianZielinski, Christoph2024-12-102024-12-102018ESMO Open . 2018 Jan 26;3(1):e000262https://hdl.handle.net/20.500.12105/25874This article is the result of a round table discussion held at the European Lung Cancer Conference (ELCC) in Geneva in May 2017. Its purpose is to explore and discuss the advances in the knowledge about the biology and treatment of brain metastases originating from -small cell lung cancer. The authors propose a series of recommendations for research and treatment within the discussed context.This initiative is sponsored by AstraZeneca through the provision of an unrestricted educational grant. AstraZeneca has had no influence over the content other than a review of the paper for medical accuracy. The participants/authors received an honorarium for their participation from BMJ.engVoRhttp://creativecommons.org/licenses/by-nc-nd/4.0/biology and treatment of brainAttribution-NonCommercial-NoDerivatives 4.0 International2938747531e000262ESMO Openopen access